NDC product
MIDAZOLAM IN 0.8% SODIUM CHLORIDE
NDC 0264-8005 · B. Braun Medical Inc.
Key facts
| Product NDC | 0264-8005 |
|---|---|
| Proprietary name | MIDAZOLAM IN 0.8% SODIUM CHLORIDE |
| Nonproprietary name | MIDAZOLAM IN 0.8% SODIUM CHLORIDE |
| Substances | MIDAZOLAM |
| Dosage form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Labeler | B. Braun Medical Inc. |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA218454 |
| DEA schedule | CIV |
| Pharmacologic classes | Benzodiazepine [EPC], Benzodiazepines [CS] |
| Marketing start | Oct 15, 2025 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: